Increased risk of fatal infections in women starting peritoneal dialysis

Peritoneal Dialysis International

Volumn 33, Issue 5, 2013, Pages 487-494

  Ros, Silvia ^a,b   Remón, Cesar ^c   Qureshi, Abdul Rashid ^a   Quiros, Pedro ^c   Lindholm, Bengt ^a   Carrero, Juan Jesús ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Nephrology Department   (Sweden)

^c HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

Author keywords

Female; Gender; Hormones; Male; Sex

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC GLOMERULONEPHRITIS; COHORT ANALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETIC NEPHROPATHY; DISEASE REGISTRY; FATALITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; INFECTION RISK; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; SEPSIS; SEX DIFFERENCE; VASCULAR DISEASE; VIRUS INFECTION;

FEMALE; GENDER; HORMONES; MALE; SEX;

CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORBIDITY; PERITONEAL DIALYSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; SWEDEN; TIME FACTORS;

EID: 84885791997     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2012.00243     Document Type: Article

References (26)

1. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3:1526-33.
2. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovacular mortality among patients starting dialysis. JAMA 2009; 302:1782-9.
3. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58:1758-64.
4. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-76.
5. Kardys I, Vliegenthart R, Oudkerk M, Hofman A, Witteman JC. The female advantage in cardiovascular disease: do vascular beds contribute equally? Am J Epidemiol 2007; 166:403-12.
6. Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR. Chronic kidney disease and life expectancy. Nephrol Dial Transplant 2012; 27:3182-6.
7. Carrero JJ, de Mutsert R, Axelsson J, Dekkers OM, Jager KJ, Boeschoten EW, et al. Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant 2011; 26:270-6.
8. Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007; 18:2125-34.
9. Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, et al. Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol 2011; 6:1722-30.
10. Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010; 33:383-92.
11. Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25:274-84.
12. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JG, Stevens P, et al. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int 1999; 55:1476-85.
13. Remón Rodríguez C, Quirós Ganga PL, Gil Cunquero JM, Ros Ruiz S, Aresté Fosalba N, Ruiz Fernández A, et al. Ten years of peritoneal dialysis in Andalusia (1999-2008): epidemiologic data, types of treatment, peritonitis, comorbidity and survival in patients and technique. Nefrologia 2010; 30:46-53.
14. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Am J Stat Assoc 1999; 94:496-509.
15. van Manen JG, van Dijk PC, Stel VS, Dekker FW, Clèries M, Conte F, et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007; 22:187-95.
16. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999; 55:1081-90.
17. Foley RN. Infectious complications in chronic dialysis patients. Perit Dial Int 2008; 28(Suppl 3):S167-71.
18. O'Seaghdha CM, Foley RN. Septicemia, access, cardiovascular disease, and death in dialysis patients. Perit Dial Int 2005; 25:534-40.
19. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol 1994; 5:1231-42.
20. Kotsanas D, Polkinghorne KR, Korman TM, Atkins RC, Brown F. Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection? Nephrology (Carlton) 2007; 12:239-45.
21. Snider H, Lezama-Davila C, Alexander J, Satoskar AR. Sex hormones and modulation of immunity against leishmaniasis. Neuroimmunomodulation 2009; 16:106-13.
22. McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz) 2011; 59:203-13.
23. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5(Suppl A):S3-10.
24. Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, et al. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol 2012; 7:207-15.
25. Kramer HM, Curhan G, Singh A on behalf of the HELP Study Group. Hemodialysis and Estrogen Levels in Postmenopausal (HELP) patients: the Multicenter HELP Study. Am J Kidney Dis 2003; 41:1240-6.
26. Weisinger JR, Bellorin-Font E. Outcomes associated with hypogonadism in women with chronic kidney disease. Adv Chron Kidney Dis 2004; 11:361-70.